MD.MUSHFIQUR RAHMAN: Open Payments
NPI 1013144211 · WILKES BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 76 payments from 13 companies in 2025. Trend: 2023 $415 · 2024 $722 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $221 |
| ABBVIE INC. | 13 | $152 |
| E.R. Squibb & Sons, L.L.C. | 11 | $147 |
| Otsuka America Pharmaceutical, Inc. | 9 | $142 |
| Alkermes, Inc. | 7 | $136 |
| Janssen Pharmaceuticals, Inc | 6 | $113 |
| Braeburn Inc. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 5 | $84 |
| Indivior Inc. | 3 | $63 |
| Neurocrine BioSciences, Inc. | 3 | $48 |
Products named: CAPLYTA, VRAYLAR, COBENFY, INVEGA SUSTENNA, ARISTADA, BRIXADI, UZEDY, SUBLOCADE.
Industry payments across PA — which companies pay providers there.
